Antiamyloid therapies for Alzheimer's disease: an experts' dialogue on facts and controversies.
作者信息
Caramelli Paulo
机构信息
Universidade Federal de Minas Gerais, Faculdade de Medicina, Unidade de Neurologia Cognitiva e do Comportamento, Belo Horizonte MG, Brazil.
出版信息
Arq Neuropsiquiatr. 2025 May;83(5):1-2. doi: 10.1055/s-0045-1808083. Epub 2025 May 9.
Abstract
摘要
相似文献
1
Antiamyloid therapies for Alzheimer's disease: an experts' dialogue on facts and controversies.阿尔茨海默病的抗淀粉样蛋白疗法：专家关于事实与争议的对话
Arq Neuropsiquiatr. 2025 May;83(5):1-2. doi: 10.1055/s-0045-1808083. Epub 2025 May 9.
2
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
3
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.美国国立卫生研究院科学现状会议声明：预防阿尔茨海默病和认知衰退
NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30.
4
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2000;2002(2):CD000147. doi: 10.1002/14651858.CD000147.
5
Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference.基因决定的阿尔茨海默病研究进展：2024年唐氏综合征与常染色体显性阿尔茨海默病会议
Alzheimers Dement. 2025 Jul;21(7):e70309. doi: 10.1002/alz.70309.
6
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
7
Practical Guide of the Korean Association for Geriatric Psychiatry to Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer's Disease: Focused on Lecanemab.韩国老年精神医学协会阿尔茨海默病抗淀粉样蛋白单克隆抗体治疗实用指南：聚焦于乐卡奈单抗
J Korean Med Sci. 2025 Jul 21;40(28):e215. doi: 10.3346/jkms.2025.40.e215.
8
Accounting for Patient Characteristics in a Model-Based Kappa of Agreement Between Two Experts' Ordinal Ratings.在基于模型的两位专家有序评分一致性卡帕值中考虑患者特征
Stat Med. 2025 Jul;44(15-17):e70141. doi: 10.1002/sim.70141.
9
Deep brain stimulation for the treatment of Alzheimer's disease: A safer and more effective strategy.深部脑刺激治疗阿尔茨海默病：一种更安全、更有效的策略。
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01088.
10
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
本文引用的文献
1
Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer's disease.抗β-淀粉样蛋白的单克隆抗体（来卡奈单抗和多奈单抗）不应被用于治疗阿尔茨海默病。
Arq Neuropsiquiatr. 2025 May;83(5):1-5. doi: 10.1055/s-0045-1808082. Epub 2025 May 9.
2
Amyloid immunotherapy for Alzheimer's disease: the case for cautious adoption.用于阿尔茨海默病的淀粉样蛋白免疫疗法：谨慎采用的理由。
Arq Neuropsiquiatr. 2025 May;83(5):1-4. doi: 10.1055/s-0045-1807718. Epub 2025 May 9.
3
Use of anti-amyloid therapies for Alzheimer's disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.巴西抗淀粉样蛋白疗法用于阿尔茨海默病治疗：巴西神经科学院认知神经病学与衰老科学部立场文件
Dement Neuropsychol. 2024 Nov 11;18:e2024C002. doi: 10.1590/1980-5764-DN-2024-C002. eCollection 2024.
4
Alzheimer's disease: part 2 - the present.阿尔茨海默病：第 2 部分-现状。
Arq Neuropsiquiatr. 2024 Jun;82(6):1-9. doi: 10.1055/s-0044-1791755. Epub 2024 Nov 11.
5
Insights into the use of biomarkers in clinical trials in Alzheimer's disease.浅析生物标志物在阿尔茨海默病临床试验中的应用。
EBioMedicine. 2024 Oct;108:105322. doi: 10.1016/j.ebiom.2024.105322. Epub 2024 Oct 3.
6
Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer's disease: a systematic review and meta-analysis.抗淀粉样蛋白-β单克隆抗体治疗早期阿尔茨海默病的疗效：系统评价和荟萃分析。
Neurol Sci. 2024 Jun;45(6):2461-2469. doi: 10.1007/s10072-023-07194-w. Epub 2023 Nov 17.
7
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease.抗淀粉样蛋白单克隆抗体治疗阿尔茨海默病。
BioDrugs. 2024 Jan;38(1):5-22. doi: 10.1007/s40259-023-00633-2. Epub 2023 Nov 13.
8
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
9
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
10
Prevalence of dementia in Latin America and Caribbean countries: Systematic review and meta-analyses exploring age, sex, rurality, and education as possible determinants.拉丁美洲和加勒比国家痴呆症的患病率：系统评价和荟萃分析探讨了年龄、性别、农村地区和教育等可能的决定因素。
Ageing Res Rev. 2022 Nov;81:101703. doi: 10.1016/j.arr.2022.101703. Epub 2022 Aug 3.
Zotero 插件